Loading…

Genomic discovery of potent chromatin insulators for human gene therapy

A genome-wide analysis of CTCF binding sites yields compact sequence elements that function as chromatin insulators. Insertional mutagenesis and genotoxicity, which usually manifest as hematopoietic malignancy, represent major barriers to realizing the promise of gene therapy. Although insulator seq...

Full description

Saved in:
Bibliographic Details
Published in:Nature biotechnology 2015-02, Vol.33 (2), p.198-203
Main Authors: Liu, Mingdong, Maurano, Matthew T, Wang, Hao, Qi, Heyuan, Song, Chao-Zhong, Navas, Patrick A, Emery, David W, Stamatoyannopoulos, John A, Stamatoyannopoulos, George
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A genome-wide analysis of CTCF binding sites yields compact sequence elements that function as chromatin insulators. Insertional mutagenesis and genotoxicity, which usually manifest as hematopoietic malignancy, represent major barriers to realizing the promise of gene therapy. Although insulator sequences that block transcriptional enhancers could mitigate or eliminate these risks, so far no human insulators with high functional potency have been identified. Here we describe a genomic approach for the identification of compact sequence elements that function as insulators. These elements are highly occupied by the insulator protein CTCF, are DNase I hypersensitive and represent only a small minority of the CTCF recognition sequences in the human genome. We show that the elements identified acted as potent enhancer blockers and substantially decreased the risk of tumor formation in a cancer-prone animal model. The elements are small, can be efficiently accommodated by viral vectors and have no detrimental effects on viral titers. The insulators we describe here are expected to increase the safety of gene therapy for genetic diseases.
ISSN:1087-0156
1546-1696
DOI:10.1038/nbt.3062